ICSI and conventional IVF, which one should be prefered for cases of pre-implantation genetic testing?
Tác giả: Nguyen Thi Cam Van, Truong Van Hanh, Nguyen Thi Nhu Trang, Tran Tran Hue, Khuat Huu Quan, Le Thi Phuong Lan, Vu Thi Tho, Tran Thi Kim LienTóm tắt:
Ever since its implementation in 1992, the intra-cytoplasmic sperm injection (ICSI) technique has been hailed as a game-changer for enhancing the outcomes of in vitro fertilization (IVF) treatment in cases of infertility due to male factors. However, ICSI was later widely applied to cases of infertility not due to male factors without evidence proving its effectiveness. According to the 2022 report of the European IVF Monitoring Council (EIM), the rate of fertilization cases using ICSI method accounts for 70% of IVF cases in European countries, meanwhile the conventional IVF method accounts for only 30% and this rate has remained stable from 2006 until recently. The question is whether cases of infertility not due to male factors that are indicated for pre-implantation genetic testing (PGT) should be fertilized and create embryos using ICSI or conventional IVF to minimize invasiveness and reduce costs while still ensuring the accuracy of the test results.
- Value of Non-invasive Prenatal Test (NIPT) for comprehensive fetal aneuploidies screening
- Dydrogesterone-primed ovarian stimulation versus gnrh antagonist protocol in in-vitro fertilization for poor responders: A pilot study
- Early diagnostis of splenic ectopic pregnancy: A case report and review literature
- Fetal - maternal hemorrhage: A comparison of two cases
- Detection of pathogenic variants related to severe dominant monogenic diseases by non-invasive prenatal testing (NIPT-SGD)